179 related articles for article (PubMed ID: 21621439)
1. Glucocerebrosidase mutations do not cause increased Lewy body pathology in Parkinson's disease.
Parkkinen L; Neumann J; O'Sullivan SS; Holton JL; Revesz T; Hardy J; Lees AJ
Mol Genet Metab; 2011 Aug; 103(4):410-2. PubMed ID: 21621439
[TBL] [Abstract][Full Text] [Related]
2. Glucocerebrosidase activity in Parkinson's disease with and without GBA mutations.
Alcalay RN; Levy OA; Waters CC; Fahn S; Ford B; Kuo SH; Mazzoni P; Pauciulo MW; Nichols WC; Gan-Or Z; Rouleau GA; Chung WK; Wolf P; Oliva P; Keutzer J; Marder K; Zhang X
Brain; 2015 Sep; 138(Pt 9):2648-58. PubMed ID: 26117366
[TBL] [Abstract][Full Text] [Related]
3. Glucocerebrosidase mutations in clinical and pathologically proven Parkinson's disease.
Neumann J; Bras J; Deas E; O'Sullivan SS; Parkkinen L; Lachmann RH; Li A; Holton J; Guerreiro R; Paudel R; Segarane B; Singleton A; Lees A; Hardy J; Houlden H; Revesz T; Wood NW
Brain; 2009 Jul; 132(Pt 7):1783-94. PubMed ID: 19286695
[TBL] [Abstract][Full Text] [Related]
4. Glucocerebrosidase enzyme activity in GBA mutation Parkinson's disease.
Ortega RA; Torres PA; Swan M; Nichols W; Boschung S; Raymond D; Barrett MJ; Johannes BA; Severt L; Shanker V; Hunt AL; Bressman S; Pastores GM; Saunders-Pullman R
J Clin Neurosci; 2016 Jun; 28():185-6. PubMed ID: 26857292
[TBL] [Abstract][Full Text] [Related]
5. Association of glucocerebrosidase mutations with dementia with lewy bodies.
Clark LN; Kartsaklis LA; Wolf Gilbert R; Dorado B; Ross BM; Kisselev S; Verbitsky M; Mejia-Santana H; Cote LJ; Andrews H; Vonsattel JP; Fahn S; Mayeux R; Honig LS; Marder K
Arch Neurol; 2009 May; 66(5):578-83. PubMed ID: 19433657
[TBL] [Abstract][Full Text] [Related]
6. Glucocerebrosidase is present in α-synuclein inclusions in Lewy body disorders.
Goker-Alpan O; Stubblefield BK; Giasson BI; Sidransky E
Acta Neuropathol; 2010 Nov; 120(5):641-9. PubMed ID: 20838799
[TBL] [Abstract][Full Text] [Related]
7. Survival and dementia in GBA-associated Parkinson's disease: The mutation matters.
Cilia R; Tunesi S; Marotta G; Cereda E; Siri C; Tesei S; Zecchinelli AL; Canesi M; Mariani CB; Meucci N; Sacilotto G; Zini M; Barichella M; Magnani C; Duga S; Asselta R; Soldà G; Seresini A; Seia M; Pezzoli G; Goldwurm S
Ann Neurol; 2016 Nov; 80(5):662-673. PubMed ID: 27632223
[TBL] [Abstract][Full Text] [Related]
8. Glucocerebrosidase mutations and neuropsychiatric phenotypes in Parkinson's disease and Lewy body dementias: Review and meta-analyses.
Creese B; Bell E; Johar I; Francis P; Ballard C; Aarsland D
Am J Med Genet B Neuropsychiatr Genet; 2018 Mar; 177(2):232-241. PubMed ID: 28548708
[TBL] [Abstract][Full Text] [Related]
9. Advances in GBA-associated Parkinson's disease--Pathology, presentation and therapies.
Barkhuizen M; Anderson DG; Grobler AF
Neurochem Int; 2016 Feb; 93():6-25. PubMed ID: 26743617
[TBL] [Abstract][Full Text] [Related]
10. β-Glucocerebrosidase gene mutations in two cohorts of Greek patients with sporadic Parkinson's disease.
Moraitou M; Hadjigeorgiou G; Monopolis I; Dardiotis E; Bozi M; Vassilatis D; Vilageliu L; Grinberg D; Xiromerisiou G; Stefanis L; Michelakakis H
Mol Genet Metab; 2011; 104(1-2):149-52. PubMed ID: 21745757
[TBL] [Abstract][Full Text] [Related]
11. Mutations in the glucocerebrosidase gene are associated with early-onset Parkinson disease.
Clark LN; Ross BM; Wang Y; Mejia-Santana H; Harris J; Louis ED; Cote LJ; Andrews H; Fahn S; Waters C; Ford B; Frucht S; Ottman R; Marder K
Neurology; 2007 Sep; 69(12):1270-7. PubMed ID: 17875915
[TBL] [Abstract][Full Text] [Related]
12. GBA Mutations Are Associated With Earlier Onset and Male Sex in Dementia With Lewy Bodies.
Gámez-Valero A; Prada-Dacasa P; Santos C; Adame-Castillo C; Campdelacreu J; Reñé R; Gascón-Bayarri J; Ispierto L; Álvarez R; Ariza A; Beyer K
Mov Disord; 2016 Jul; 31(7):1066-70. PubMed ID: 27027900
[TBL] [Abstract][Full Text] [Related]
13. Mutations in glucocerebrosidase are a major genetic risk factor for Parkinson's disease and increase susceptibility to dementia in a Flanders-Belgian cohort.
Crosiers D; Verstraeten A; Wauters E; Engelborghs S; Peeters K; Mattheijssens M; De Deyn PP; Theuns J; Van Broeckhoven C; Cras P
Neurosci Lett; 2016 Aug; 629():160-164. PubMed ID: 27397011
[TBL] [Abstract][Full Text] [Related]
14. Selective loss of glucocerebrosidase activity in sporadic Parkinson's disease and dementia with Lewy bodies.
Chiasserini D; Paciotti S; Eusebi P; Persichetti E; Tasegian A; Kurzawa-Akanbi M; Chinnery PF; Morris CM; Calabresi P; Parnetti L; Beccari T
Mol Neurodegener; 2015 Mar; 10():15. PubMed ID: 25881142
[TBL] [Abstract][Full Text] [Related]
15. Characterization of Brain Lysosomal Activities in GBA-Related and Sporadic Parkinson's Disease and Dementia with Lewy Bodies.
Moors TE; Paciotti S; Ingrassia A; Quadri M; Breedveld G; Tasegian A; Chiasserini D; Eusebi P; Duran-Pacheco G; Kremer T; Calabresi P; Bonifati V; Parnetti L; Beccari T; van de Berg WDJ
Mol Neurobiol; 2019 Feb; 56(2):1344-1355. PubMed ID: 29948939
[TBL] [Abstract][Full Text] [Related]
16. Clinicogenetic study of GBA mutations in patients with familial Parkinson's disease.
Li Y; Sekine T; Funayama M; Li L; Yoshino H; Nishioka K; Tomiyama H; Hattori N
Neurobiol Aging; 2014 Apr; 35(4):935.e3-8. PubMed ID: 24126159
[TBL] [Abstract][Full Text] [Related]
17. Genetic modifiers of risk and age at onset in GBA associated Parkinson's disease and Lewy body dementia.
Blauwendraat C; Reed X; Krohn L; Heilbron K; Bandres-Ciga S; Tan M; Gibbs JR; Hernandez DG; Kumaran R; Langston R; Bonet-Ponce L; Alcalay RN; Hassin-Baer S; Greenbaum L; Iwaki H; Leonard HL; Grenn FP; Ruskey JA; Sabir M; Ahmed S; Makarious MB; Pihlstrøm L; Toft M; van Hilten JJ; Marinus J; Schulte C; Brockmann K; Sharma M; Siitonen A; Majamaa K; Eerola-Rautio J; Tienari PJ; ; Pantelyat A; Hillis AE; Dawson TM; Rosenthal LS; Albert MS; Resnick SM; Ferrucci L; Morris CM; Pletnikova O; Troncoso J; Grosset D; Lesage S; Corvol JC; Brice A; Noyce AJ; Masliah E; Wood N; Hardy J; Shulman LM; Jankovic J; Shulman JM; Heutink P; Gasser T; Cannon P; Scholz SW; Morris H; Cookson MR; Nalls MA; Gan-Or Z; Singleton AB
Brain; 2020 Jan; 143(1):234-248. PubMed ID: 31755958
[TBL] [Abstract][Full Text] [Related]
18. Glucocerebrosidase mutations influence the natural history of Parkinson's disease in a community-based incident cohort.
Winder-Rhodes SE; Evans JR; Ban M; Mason SL; Williams-Gray CH; Foltynie T; Duran R; Mencacci NE; Sawcer SJ; Barker RA
Brain; 2013 Feb; 136(Pt 2):392-9. PubMed ID: 23413260
[TBL] [Abstract][Full Text] [Related]
19. Association of glucocerebrosidase polymorphisms and mutations with dementia in incident Parkinson's disease.
Lunde KA; Chung J; Dalen I; Pedersen KF; Linder J; Domellöf ME; Elgh E; Macleod AD; Tzoulis C; Larsen JP; Tysnes OB; Forsgren L; Counsell CE; Alves G; Maple-Grødem J
Alzheimers Dement; 2018 Oct; 14(10):1293-1301. PubMed ID: 29792872
[TBL] [Abstract][Full Text] [Related]
20. β-Glucocerebrosidase activity in
Huh YE; Chiang MSR; Locascio JJ; Liao Z; Liu G; Choudhury K; Kuras YI; Tuncali I; Videnovic A; Hunt AL; Schwarzschild MA; Hung AY; Herrington TM; Hayes MT; Hyman BT; Wills AM; Gomperts SN; Growdon JH; Sardi SP; Scherzer CR
Neurology; 2020 Aug; 95(6):e685-e696. PubMed ID: 32540937
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
